550 related articles for article (PubMed ID: 1673821)
1. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
[TBL] [Abstract][Full Text] [Related]
2. Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
Pellicciari C; Mangiarotti R; Bottone MG; Danova M; Wang E
Cytometry; 1995 Dec; 21(4):329-37. PubMed ID: 8608730
[TBL] [Abstract][Full Text] [Related]
3. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects of the inhibition of DNA synthesis on it.
Sasaki K; Kurose A; Ishida Y
Cytometry; 1993 Nov; 14(8):876-82. PubMed ID: 7904555
[TBL] [Abstract][Full Text] [Related]
5. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
Gelb AB; Kamel OW; LeBrun DP; Warnke RA
Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
[TBL] [Abstract][Full Text] [Related]
6. Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry.
Lohr F; Wenz F; Haas S; Flentje M
Cell Prolif; 1995 Feb; 28(2):93-104. PubMed ID: 7893842
[TBL] [Abstract][Full Text] [Related]
7. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry.
Kurki P; Ogata K; Tan EM
J Immunol Methods; 1988 Apr; 109(1):49-59. PubMed ID: 2895795
[TBL] [Abstract][Full Text] [Related]
9. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
[TBL] [Abstract][Full Text] [Related]
10. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
Teague K; el-Naggar A
Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
[TBL] [Abstract][Full Text] [Related]
11. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA)/cyclin expression during the cell cycle in normal and leukemic cells.
Giordano M; Danova M; Pellicciari C; Wilson GD; Mazzini G; Conti AM; Franchini G; Riccardi A; Romanini MG
Leuk Res; 1991; 15(11):965-74. PubMed ID: 1683676
[TBL] [Abstract][Full Text] [Related]
13. Expression of proliferation associated antigens in the cell cycle of synchronized mammalian cells.
Bolton WE; Mikulka WR; Healy CG; Schmittling RJ; Kenyon NS
Cytometry; 1992; 13(2):117-26. PubMed ID: 1372207
[TBL] [Abstract][Full Text] [Related]
14. G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6).
El-Sherbiny YM; Cox MC; Ismail ZA; Shamsuddin AM; Vucenik I
Anticancer Res; 2001; 21(4A):2393-403. PubMed ID: 11724298
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
Danova M; Pellicciari C; Zibera C; Mangiarotti R; Gibelli N; Giordano M; Wang E; Mazzini G; Riccardi A
Ann N Y Acad Sci; 1993 Nov; 698():174-81. PubMed ID: 7904138
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
19. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
Coltrera MD; Gown AM
J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.
Roos G; Landberg G; Huff JP; Houghten R; Takasaki Y; Tan EM
Lab Invest; 1993 Feb; 68(2):204-10. PubMed ID: 7680082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
